Viewing data from:

TILADE

NDA

NEDOCROMIL SODIUM | N019660 | KING PHARMACEUTICALS LLC

1 strength0 unique patents0 unique exclusivities

PTAB Proceedings

No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board

Patent Reexaminations

No ex parte or inter partes reexamination proceedings found at USPTO

Hatch-Waxman Litigation

No ANDA patent litigation cases (NOS 835) matched from PACER

Citizen Petitions

No FDA citizen petitions matched from Regulations.gov

Clinical Trials

No clinical trials found on ClinicalTrials.gov for this drug

API Supply Chain0 active DMFs2 inactive

0 active API suppliers hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

FISONS PHARMACEUTICAL LTDInactiveNEDOCROMIL SODIUM

DMF 65131986

AVENTIS PHARMA MANUFACTURING PTE LTDInactiveNEDOCROMIL SODIUM

DMF 109441994

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Mar 2, 2004	SUPPL -17	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — 1.75MG/INH

0 patents0 exclusivities▴

AEROSOL, METERED;INHALATION | Approved: Dec 30, 1992

No patent or exclusivity listings for this strength.